Target intelligence / Profile preview

Human fibroblasts

Molecular classification
Cell type, Other
01

Overview

Human fibroblasts are the primary cellular components of connective tissue, responsible for synthesizing the extracellular matrix (ECM) and collagen required for tissue integrity and repair. While essential for normal physiological processes such as wound healing and structural maintenance, fibroblasts are central to the pathogenesis of various fibroproliferative diseases and the tumor microenvironment. In conditions like pulmonary fibrosis or scleroderma, activated fibroblasts (myofibroblasts) produce excessive ECM, leading to organ dysfunction. In oncology, cancer-associated fibroblasts (CAFs) promote tumor progression, immune evasion, and drug resistance. Because 'Human fibroblasts' refers to a heterogeneous cell population rather than a specific protein or receptor, it is classified as a cellular target or a system rather than a single molecular therapeutic target. Drugs targeting fibroblast activity typically aim at specific signaling pathways, such as TGF-beta or various receptor tyrosine kinases, to prevent pathological tissue remodeling.

Other names
FibrocytesConnective tissue cellsStromal cellsDermal fibroblasts
02

Mechanism of action

Modulation of fibroblast proliferation, inhibition of myofibroblast differentiation, and reduction of extracellular matrix deposition.

03

Biological functions

Extracellular matrix synthesisWound healingTissue repairStructural supportCytokine productionInflammation modulation
04

Disease associations

FibrosisCancer (Cancer-associated fibroblasts)SclerodermaRheumatoid arthritisHypertrophic scarringOrgan failure
05

Safety considerations

Impaired wound healingSystemic tissue repair disruptionOff-target effects on healthy stromal architecture
06

Interacting drugs

Pirfenidone

4 more in the full profile.

07

Biomarkers

VimentinAlpha-smooth muscle actin (alpha-SMA)Fibroblast-specific protein 1 (FSP1)Fibroblast activation protein (FAP)Type I collagen

Beyond the preview

Go deeper on Human fibroblasts.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human fibroblasts.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call